Tacrolimus 0.03 % Topical Ointment
RxNorm 313189
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 313189 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tacrolimus 0.03 % Topical Ointment.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Tacrolimus 0.0003 mg/MG Topical Ointment
(Atom ID: 12340059)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug)
(Atom ID: 12666102)
SYPrescribable
Synonym (SY):
Tacrolimus (as tacrolimus monohydrate) 0.0003 mg/MG Topical Ointment
(Atom ID: 11449842)
PSNPrescribable
Prescribable Name (PSN):
Tacrolimus 0.03 % Topical Ointment
(Atom ID: 6382173)
SYPrescribable
Synonym (SY):
Tacrolimus 0.03 % Topical Ointment
(Atom ID: 3292695)
PTPrescribable
Designated preferred name (PT):
Tacrolimus 300 microgram/g cutaneous ointment
(Atom ID: 12666308)
Patient Education
Tacrolimus Topical
Tacrolimus ointment is used to treat the symptoms of eczema (atopic dermatitis; a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in patients who cannot use other medications for their condition or whose eczema has not responded to another medication. Tacrolimus is in a class of medications called topical calcineurin inhibitors. It works by stopping the immune system from producing substances that may cause eczema.
[Learn More]
* Please review the disclaimer below.